Finnish Funding Agency for Innovation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Finnish Funding Agency for Innovation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014012
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Finnish Funding Agency for Innovation (Tekes) is a financing organization that offers research and technological development programs. The organization offers financial services for research, development and novelty. It provides finance for research and development of new technologies, business concepts, networking and management practices. Tekes provides funding services for corporations, universities, research institutions, and government organizations, local and regional authorities. The organization concentrates on research and development collaboration in the areas of information and telecommunication technologies; biotechnology and healthcare systems; and nanotechnology, among others. The organization helps companies to enhance their networking and development potential. It has presence in Belgium, Finland, Russia, China, and the US. Tekes is headquartered in Helsinki, Finland.

Finnish Funding Agency for Innovation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Finnish Funding Agency for Innovation, Medical Devices Deals, 2011 to YTD 2017 9
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Euformatics Raises USD0.4 Million in Seed Financing 11
Blueprint Genetics Raises USD4 Million in Seed Venture Financing 12
DelSiTech Raises up to USD2.34 Million in Venture Financing 13
TILT Biotherapeutics Raises Funds through Seed Financing 14
Mobidiag Raises Funds Through Venture Financing 15
Plexpress Raises US$1.4 Million In Initial Closing Of Venture Financing Round 17
FKD Therapies Secures US$16 Million In Venture Financing 18
Finnish Funding Agency for Innovation – Key Competitors 19
Finnish Funding Agency for Innovation – Key Employees 20
Finnish Funding Agency for Innovation – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Government and Public Interest 22
Sep 14, 2016: Montisera receives major governmental funding from Tekes for initiating the pilot production of the company’s spruce hot water extract molecule 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Key Facts 2
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Finnish Funding Agency for Innovation, Deals By Therapy Area, 2011 to YTD 2017 8
Finnish Funding Agency for Innovation, Medical Devices Deals, 2011 to YTD 2017 9
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Euformatics Raises USD0.4 Million in Seed Financing 11
Blueprint Genetics Raises USD4 Million in Seed Venture Financing 12
DelSiTech Raises up to USD2.34 Million in Venture Financing 13
TILT Biotherapeutics Raises Funds through Seed Financing 14
Mobidiag Raises Funds Through Venture Financing 15
Plexpress Raises US$1.4 Million In Initial Closing Of Venture Financing Round 17
FKD Therapies Secures US$16 Million In Venture Financing 18
Finnish Funding Agency for Innovation, Key Competitors 19
Finnish Funding Agency for Innovation, Key Employees 20
Finnish Funding Agency for Innovation, Other Locations 21
Finnish Funding Agency for Innovation, Subsidiaries 21

★海外企業調査レポート[Finnish Funding Agency for Innovation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marubeni Corporation:企業の戦略・SWOT・財務情報
    Marubeni Corporation - Strategy, SWOT and Corporate Finance Report Summary Marubeni Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Acarix AS:医療機器:M&Aディール及び事業提携情報
    Summary Acarix A/S (Acarix) is a medical device company that provides design and development of non-invasive cardiac screening products. The company provides non-invasive screening device, CADScor system used to record, process and display heart signals as a patient specific score as the CAD-score o …
  • Power Assets Holdings Limited:企業の戦略・SWOT・財務分析
    Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • Laboratories Ojer Pharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratories Ojer Pharma SL (Ojer Pharma) is a developer of pharmaceutical products in dermatology. The company's products categories include prescription medicine, over the counter OTC, medical devices and cosmetic products. It offers products such as previderm, dermatul nasal, dermatul lip …
  • Innovation Pharmaceuticals Inc (IPIX)-医療機器分野:企業M&A・提携分析
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company pipeline products include kevetrin for the …
  • Marshall of Cambridge (Holdings) Ltd:戦略・SWOT・企業財務分析
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Biosense Webster Inc:企業の製品パイプライン分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Ekarat Engineering (Public) Co Ltd (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co Ltd (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Insightra Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company offers cardiovascular and surgical solutions. Its cardiovascular solutions include Ultra 7FR IAB and modulare. The Modulare Cathe …
  • Cummins Inc (CMI):電力:M&Aディール及び事業提携情報
    Summary Cummins Inc. (Cummins), formerly Cummins Engine Company, is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment dev …
  • meteocontrol GmbH:電力:M&Aディール及び事業提携情報
    Summary Meteocontrol GmbH (meteocontrol) a subsidiary of S.A.G. Solar GmbH & Co. KG, is a renewable energy company which offers photovoltaic monitoring solutions. The company's product portfolio includes data loggers, WEB'logs, portals, sensor system, grid feed-in management or power control, SCADA …
  • Cloud Cap Technology Inc.:企業の戦略・SWOT・財務情報
    Cloud Cap Technology Inc. - Strategy, SWOT and Corporate Finance Report Summary Cloud Cap Technology Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • American Greetings Corporation:企業の戦略的SWOT分析
    American Greetings Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Noble Energy, Inc.:戦略・SWOT・企業財務分析
    Noble Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noble Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vanguard Natural Resources, LLC (VNRSQ)-石油・ガス分野:企業M&A・提携分析
    Summary Vanguard Natural Resources, LLC (Vanguard) is an upstream company. It acquires, produces, and develops oil and natural gas properties. The company owns Green River Basin, Permian Basin, Piceance Basin, Gulf Coast Basin, Arkoma Basin, Big Horn Basin, Williston Basin, Anadarko Basin, and Wind …
  • TriLink BioTechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary TriLink BioTechnologies Inc (TriLink), a subsidiary of Maravai Life Sciences Inc, is a manufacturer of modified nucleic acid products. The company’s products include oligonucleotides, nucleotides, custom chemistry, DNA synthesis reagents, cleanamp PCR products, modified nucleoside triphospha …
  • Unisys Corp (UIS):企業の財務・戦略的SWOT分析
    Unisys Corp (UIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ADx NeuroSciences NV:企業の製品パイプライン分析2018
    Summary ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analyti …
  • Lincoln Electric Holdings Inc:企業の戦略・SWOT・財務分析
    Lincoln Electric Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Lincoln Electric Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆